Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
814.00    20.00 (2.52%)
Bid:
804.00
Ask:
814.00
Spread: 10.00 (1.244%)
Market Cap: £375.22m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Pre-close Trading Update and Acquisition

8 Dec 2017 07:00

RNS Number : 7434Y
Porvair PLC
08 December 2017
 

For immediate release 8 December 2017

 

 

Porvair PLC

 

Pre-close trading update and acquisition

 

Porvair plc ("Porvair", "the Group" or "the Company"), the specialist filtration and environmental technologies group, announces the following trading update and acquisition ahead of its close period for the year ended 30 November 2017.

Trading update

Revenue growth for the year ended 30 November 2017 was 6%. Underlying revenue(1) growth was 11% overall, with underlying revenue growth of 13% in the Microfiltration division and 1% in the Metals Filtration division. Earnings for the year are forecast to be ahead of management's expectations.

Net cash at the 30 November 2017 was £9.7 million (2016: £13.6 million), after capital and acquisition expenditure of approximately £11 million. Group order books for the start of the 2018 financial year are healthy. 

New divisional structure

Recognising the Group's growth in recent years, and as noted in the 2017 interim report, the Board will change the Group's management and reporting structure in 2018 to one that offers better management and market focus and greater investor clarity. The 2017 Report and Accounts will use the current two division structure, but will include proforma information for the new three new divisions, which will serve distinct markets: Aerospace & Industrial; Laboratory; and Molten Metals.

Acquisition

The new Laboratory division, which will focus on filtration and sample preparation products, acquired Rohasys B.V., a Dutch company, on 7 December 2017. This small acquisition brings robotic sample handling expertise to the division, which will enhance the Group's growing bioscience sample preparation capabilities.

Date of preliminary announcement

Porvair will announce its preliminary results for the year ended 30 November 2017 on Monday 29 January 2018.

Market Abuse Regime

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation. Upon the publication of this announcement via a regulatory information service, this inside information is now considered to be in the public domain.

Note (1) Underlying revenue: Revenue at constant currency excluding the impact of large projects.

 

For further information, please contact:

Porvair plc

 

01553 765 500

Ben Stocks, Chief Executive

 

 

Chris Tyler, Group Finance Director

 

 

Buchanan Communications

 

0207 466 5000

Charles Ryland / Steph Watson

 

 

 

Notes to editors

 

Porvair plc

Porvair is a group of specialist filtration, separation and environmental technologies businesses. Its products are used in a range of niche filtration and separation markets, and are derived from its expertise in the design and manufacture of filtration and separation systems. From the 2018 financial year it is organised into three divisions: Aerospace & Industrial; Laboratory; and Molten Metals.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUBUNRBAAURAA
Date   Source Headline
5th Dec 20197:00 amRNSPre-close trading update
2nd Dec 201911:20 amRNSHolding(s) in Company
2nd Dec 201911:20 amRNSHolding(s) in Company
13th Nov 20192:51 pmRNSHolding(s) in Company
31st Oct 20197:00 amRNSTotal Voting Rights
8th Oct 201910:00 amRNSBlock listing update
20th Sep 201911:38 amRNSDirector/PDMR Shareholding
18th Sep 20197:00 amRNSNine months trading update
5th Sep 20197:00 amRNSAcquisition of Dahlman Industrial Group B.V.
28th Aug 201912:07 pmRNSSecond Price Monitoring Extn
28th Aug 201912:02 pmRNSPrice Monitoring Extension
23rd Aug 201912:07 pmRNSSecond Price Monitoring Extn
23rd Aug 201912:02 pmRNSPrice Monitoring Extension
6th Aug 201912:07 pmRNSSecond Price Monitoring Extn
6th Aug 201912:02 pmRNSPrice Monitoring Extension
28th Jun 201911:30 amRNSDirector/PDMR Shareholding
27th Jun 20194:35 pmRNSPrice Monitoring Extension
24th Jun 20197:00 amRNSHalf Year Results 2019
18th Jun 20197:00 amRNSBoard changes
6th Jun 20197:00 amRNSTrading Update
15th Apr 201912:30 pmRNSHolding(s) in Company
11th Apr 20193:13 pmRNSAGM resolutions
11th Apr 20197:00 amRNSAGM Trading Update
26th Mar 20194:35 pmRNSPrice Monitoring Extension
22nd Mar 201910:59 amRNSHolding(s) in Company
8th Mar 20191:33 pmRNSHolding(s) in Company
12th Feb 201912:02 pmRNSDirector/PDMR Shareholding
28th Jan 20197:00 amRNSResults for the year ended 30 November 2018
24th Dec 201812:40 pmRNSSecond Price Monitoring Extn
24th Dec 201812:35 pmRNSPrice Monitoring Extension
7th Dec 20187:00 amRNSPre-close trading update
21st Sep 20189:57 amRNSDirector/PDMR Shareholding
18th Sep 20187:00 amRNSNine months trading update
7th Sep 20184:40 pmRNSSecond Price Monitoring Extn
7th Sep 20184:35 pmRNSPrice Monitoring Extension
29th Aug 20185:06 pmRNSDirector Declaration
10th Aug 20183:00 pmRNSDirector's Shareholding
10th Jul 20183:22 pmRNSHolding(s) in Company
25th Jun 20187:00 amRNSHalf Yearly Results
6th Jun 20187:00 amRNSTrading Update
1st May 20189:50 amRNSHolding(s) in Company
18th Apr 20184:40 pmRNSSecond Price Monitoring Extn
18th Apr 20184:35 pmRNSPrice Monitoring Extension
17th Apr 20182:21 pmRNSAGM resolutions and Board changes
17th Apr 20187:00 amRNSAGM Trading Update
6th Apr 20184:40 pmRNSSecond Price Monitoring Extn
6th Apr 20184:35 pmRNSPrice Monitoring Extension
19th Mar 20186:16 pmRNSDirector's Shareholding
1st Mar 20187:00 amRNSAcquisition of Keystone Filter
14th Feb 201812:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.